During the Noble Capital Markets’ 17th Annual Small & Microcap Investor Conference, Dr. Daniela Santiesteban, Director of Research and Business Development at Salarius Pharmaceuticals, will participate in a virtual panel discussion highlighting the future of targeted cancer therapies. The panel...
Conference Call Information: Interested participants and investors may access the conference call by dialing either: (833) 423-0481 (U.S.) (918) 922-2375 (international) Conference ID: 1277839
In the News
Houston Business Journal